Axsome Therapeutics (AXSM) EPS (Weighted Average and Diluted): 2022-2025
Historic EPS (Weighted Average and Diluted) for Axsome Therapeutics (AXSM) over the last 4 years, with Sep 2025 value amounting to -$0.94.
- Axsome Therapeutics' EPS (Weighted Average and Diluted) rose 29.85% to -$0.94 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.67, marking a year-over-year increase of 29.03%. This contributed to the annual value of -$5.99 for FY2024, which is 13.66% down from last year.
- Per Axsome Therapeutics' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.94 for Q3 2025, which was up 3.09% from -$0.97 recorded in Q2 2025.
- Over the past 5 years, Axsome Therapeutics' EPS (Weighted Average and Diluted) peaked at -$0.26 during Q1 2023, and registered a low of -$2.13 during Q4 2023.
- Over the past 3 years, Axsome Therapeutics' median EPS (Weighted Average and Diluted) value was -$1.34 (recorded in 2024), while the average stood at -$1.31.
- As far as peak fluctuations go, Axsome Therapeutics' EPS (Weighted Average and Diluted) surged by 74.76% in 2023, and later plummeted by 453.85% in 2024.
- Over the past 4 years, Axsome Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$1.43 in 2022, then tumbled by 48.95% to -$2.13 in 2023, then increased by 27.70% to -$1.54 in 2024, then increased by 29.85% to -$0.94 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.94 in Q3 2025, compared to -$0.97 in Q2 2025 and -$1.22 in Q1 2025.